8-K ·Filed Apr 16, 2026
8-K Item 2.02: Earnings release
Actionable Insight • Neutral
Monitor the full earnings release in May for GAAP metrics and updated full-year guidance, which could revise sentiment. The stock may react to forward-looking commentary on market share gains in the evolving wound care landscape.
Final — all horizons settled through T+60d ⚠ clustered
SNWV ▼ -41.97% at T+60d
NEUTRAL call -41.97% · α vs SPY -48.11% · entry $20.61 → $11.96
T+1d
-3.25%
call -3.25% · α -3.06%
$19.94
settled 6mo ago
T+5d
-9.27%
call -9.27% · α -9.82%
$18.70
settled 6mo ago
T+20d
-17.18%
call -17.18% · α -22.55%
$17.07
settled 6mo ago
T+60d
-41.97%
call -41.97% · α -48.11%
$11.96
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Sanuwave Health reported preliminary Q1 2026 revenue of $9.6–9.7 million, up 3–4% year-over-year and in line with prior guidance. This follows record Q4 2025 results and reflects ongoing market transition in wound care reimbursement.
Key Financial Metrics
Revenue
$9.7M
est $9.6M · +0.5% · +3.5% YoY
Guidance
$9.6-10.3 million
maintained
Key Facts
- Preliminary Q1 2026 revenue: $9.6–9.7 million
- Represents 3–4% year-over-year growth
- In line with Q1 guidance provided in March 2026
- CEO cited delayed deals pulling results toward lower end of guidance range
- Company maintains optimism about market share gains amid wound care reimbursement shifts
Financial Impact
Revenue of $9.6–9.7 million, up 3–4% YoY
revenue
Risk Factors
- Reimbursement pressures in wound care space may continue to impact practitioner activity
- Preliminary revenue is at the lower end of prior guidance range, suggesting headwinds
Market Snapshot
Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-025553 |
| Exhibit: ex-991snwvpressreleasex416.htm | 0001628280-26-025553 |
| Document: 0001628280-26-025553-index-headers.html | 0001628280-26-025553 |
| Document: 0001628280-26-025553-index.html | 0001628280-26-025553 |
| Document: 0001628280-26-025553.txt | 0001628280-26-025553 |
| 8-K Data (Synthetic) | 0001628280-26-025553 |
13 reports for SNWV
67% Hit rate @ T+5 Went positive at some point 4 of 6 best @ T+60▲ +53.00%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | 8-K | $4.65 $4.70 | ▼ −1.08% | ▲ +0.13% | $5.13 (−10.32%) |
Aug 6, 2026 11w ago | 8-K | $5.88 $4.74 | ▲ +19.39% | ▲ +19.79% | $5.13 (+12.76%) |
Aug 6, 2026 11w ago | Press Release | $5.88 $4.74 | ▲ +19.39% | ▲ +19.79% | $5.13 (+12.76%) |
Jul 30, 2026 12w ago | Press Release | $6.17 $5.88 | ▼ −4.70% | ▼ −8.21% | $5.13 (−16.86%) |
Jun 16, 2026 19w ago | 8-K | $8.51 $8.20 | ▲ +3.64% | ▲ +1.41% | $5.13 (+39.72%) |
Jun 16, 2026 19w ago | Press Release | $8.51 $8.20 | ▲ +3.64% | ▲ +1.41% | $5.13 (+39.72%) |
Jun 11, 2026 19w ago | Institutional Cluster | $14.69 $9.09 | ▼ −38.12% | ▼ −38.55% | $5.13 (−65.08%) |
May 12, 2026 24w ago | Press Release | $18.94 $16.69 | ▼ −11.88% | ▼ −10.72% | $5.13 (−72.91%) |
May 6, 2026 24w ago | Press Release | $16.65 $18.94 | ▲ +13.75% | ▲ +12.25% | $5.13 (−69.19%) |
Apr 16, 2026 27w ago | 8-K | $20.61 $18.70 | ▼ −9.27% | ▼ −9.82% | $5.13 (−75.11%) |
Showing 10 of 13
US Market Status
Market Closed — Opens Wed (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers